Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Interviews
    • Sign up for alerts
  • About us
    • About BiO
    • Editors and Board
    • Editor biographies
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact BiO
    • Advertising
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Biology Open
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Biology Open

Advanced search

RSS   Twitter   Facebook   YouTube

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Interviews
    • Sign up for alerts
  • About us
    • About BiO
    • Editors and Board
    • Editor biographies
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact BiO
    • Advertising
    • Feedback
Research Article
A new rat model of treatment-naive quiescent choroidal neovascularization induced by human VEGF165 overexpression
Shan Liu, Antje K. Biesemeier, Alexander V. Tschulakow, Harsh V. Thakkar, Sylvie Julien-Schraermeyer, Ulrich Schraermeyer
Biology Open 2020 9: bio048736 doi: 10.1242/bio.048736 Published 11 June 2020
Shan Liu
1Center for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Tübingen 72076, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antje K. Biesemeier
1Center for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Tübingen 72076, Germany
2Natural and Medical Institute at the University of Tübingen, Applied Material Science and Electron Microscopy, Reutlingen 72770, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander V. Tschulakow
1Center for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Tübingen 72076, Germany
3STZ OcuTox Preclinical Drug Assessment, Hechingen 72379, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harsh V. Thakkar
1Center for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Tübingen 72076, Germany
3STZ OcuTox Preclinical Drug Assessment, Hechingen 72379, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvie Julien-Schraermeyer
1Center for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Tübingen 72076, Germany
3STZ OcuTox Preclinical Drug Assessment, Hechingen 72379, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrich Schraermeyer
1Center for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Tübingen 72076, Germany
3STZ OcuTox Preclinical Drug Assessment, Hechingen 72379, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ulrich Schraermeyer
  • For correspondence: ulrich.schraermeyer@med.uni-tuebingen.de
  • Article
  • Figures & tables
  • Supp info
  • Info & metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Tables

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    LM/EM of human CNV. (A) LM of a human eye with CNV. The multi-layered RPE (arrowheads) is on the right. The space between the multi-layered RPE and CC is filled with the increased extracellular matrix. Black arrows: CNV vessels. (B) EM of a human CNV vessel: varying thicknesses of endothelial cells (e), pericytes (p), multi-layered basement membranes (arrows) and extravascular erythrocytes (right side of B) can be observed. No fenestration was observed. Mitochondria are blown because of preparation artefacts, maybe due to post mortem time. CC, choriocapillaris; CNV, choroidal neovascularization; RPE, retinal pigment epithelium. Scale bar in A: 50 µm, in B: 5 µm.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    In vivo examination of the rat eyes 6 weeks after transduction with AAV-VEGF. (A) Comparison of the CNV area in FA and ICG of an eye. FA and ICG images are on the left, and the overlay image (FA signal: red; ICG signal: green; overlap: yellow) is on the right. The overlapped areas contain the retinal vessels and the CNV area in the retina. The ICG signal shows a spotty pattern stretched over a larger area than the FA signal, indicating the part of CNV below the RPE cells. (B–D) An FA angiograph (B) and corresponding OCT images (C,D) of one eye. The dashed line in C shows the decrease of the retinal thickness between the two small CNV lesions. A large CNV lesion is shown in D, corresponding to the outer rim of the ring-shaped hyper-fluorescent area in FA. No exudation in the subretinal space was found in C and D. Black arrow, CNV lesion. Scale bars: 200 µm.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    OCT (A) and LM/EM (B–E) of the same eye, 9 weeks after VEGF transduction. (A) The hill-like structure in A (black arrow) corresponds to the CNV area in B and C. *, subretinal space. (B) LM: the black arrows label the CNV area below the subretinal space (*). Large vacuoles and mild photoreceptor degeneration can be observed. The rectangles in A and B show the same region. (C) EM of the same CNV area, a CNV vessel is embedded in the multi-layered RPE. (D) Magnification of the rectangle area in C. Accumulation of collagen with visible striations in BM and between the CNV vessel and the RPE. The elastic layer of BM (white arrow) is incomplete, and a thin cell (yellow arrowhead) can be seen between CC and BM. The bifurcation of endothelial cells (yellow arrow) and abnormal basement membranes surrounding the RPE cells completely can also be observed. Black arrows, basement membranes surrounding CC and RPE; black arrowhead, fenestration; red arrow, pinocytotic vesicles. (E) Collagens are striated with a distinct periodicity. Scale bar in B: 100 µm, in C: 4 µm, in D: 1 µm, in E: 500 nm.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Ultrastructural details of typical CNV vessels. (A) A CNV vessel has penetrated through BM (magnified views in B and C). The vessel consists of endothelial cells (e) with varying thicknesses and is associated with pericytes (p). The space between the RPE cells and the CNV vessel is filled with extracellular matrix (mainly collagen) and debris of unknown origin. A small vascular lumen (**) is formed by the irregular endothelium and ‘intrusional’ growth of extracellular matrix (mainly collagen) towards the main lumen of the vessel. Large vacuolar structures (V) in the RPE layer can also be found, they show microvillar projections into the external space (black arrows). A thrombocyte can be observed in the CNV vessel. (B) Magnification of the bottom rectangle area in A. An endothelial cell with several vesicles (marked with black arrows) and a pericyte surrounded by basal membrane can be observed. Black arrowhead, endothelial projections into vessel lumen. (C) Magnification of the top rectangle area in A. Black arrows, fenestrations. (D) Another CNV vessel enveloped by RPE cells. Multi-layered basement membranes (black arrows) can be seen around the vessel. (E) Quantification of the number of fenestrations per µm circumference of the endothelium of CNV vessels and choroid capillaries. The number of fenestrations in the CNV vessels is less than in choroid capillaries (t-test, *P<0.05). The mean value and standard deviation are shown in the box figures. Scale bar in A: 5 µm, in B and C: 1 µm, in D: 2 µm.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Exemplary images of anti-human VEGF staining (A–E), RPE65 staining (F–G) and Iba1 staining (with DAPI) (H–J). (A–E) A CNV rat eye (A–C), a human AMD eye (D) and an AAV-EGFP rat eye (E) with anti-human VEGF staining. (A–C) The CNV rat eye shows an intense anti-human VEGF staining in the RPE cells within and close to the CNV lesions (A,B). The RPE far away from the CNV lesion is not stained significantly (C). A single pigmented cell without VEGF positive stain (marked with a black arrow) can be observed in the subretinal space, which might be a disconnected RPE cell or a macrophage (A). (D) The RPE cells are significantly stained with the human VEGF antibody in the human AMD eye. (E) The AAV-EGFP eye does not show intense VEGF staining in the single RPE layer. (F–G) RPE65: the RPE layer (white arrows) is multiplied in the CNV eye compared with the control in G. The multi-layered RPE corresponds to the pattern of RPE-like pigmented cells under EM. A single layer RPE can be observed in AAV-EGFP control eyes. (H–J) Iba1. (H) Bright field of a CNV rat eye. (I) The same area as in H. The CNV eye shows macrophages/activated microglia deposits in the CNV area and heavily infiltrating the retina. (J) In the AAV-EGFP control eye, no macrophages nor activated microglia in the RPE layer, PR and ONL were observed. INL, inner nuclear layer; ONL, outer nuclear layer; PR, photoreceptors; RPE, retinal pigment epithelium. Scale bar in A: 50 µm, in B–E and H–J: 20 µm, in F and G: 10 µm.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Quantification of the CNV areas in angiography and the maximal thickness of the CNV lesion and retina in OCT. (A) Comparison of CNV areas in late-phase FA from 2–9 weeks after VEGF overexpression. The CNV areas reach a stable size after 6 weeks. (B) Quantification of the maximal retinal thickness in CNV eyes from 6–9 weeks after VEGF overexpression. The normal retinal thickness is measured in the adjacent area without CNV lesions. The retina at the CNV area is thicker than the normal retina, and it continues to thicken over time (ANOVA, *P<0.05). (C) Quantification of the maximal CNV lesion thickness in CNV eyes. The CNV lesion thickness increases significantly between 6 and 9 weeks after VEGF transduction (ANOVA, *P<0.05). au=arbitrary units. *P<0.05 (ANOVA). The mean value and standard deviation are shown in the box figures.

  • Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Change of the maximal retinal (A), CNV lesion thickness (B) and VEGF expression (C) after bevacizumab treatment. (A,B) Bevacizumab can reduce the retinal and CNV lesion thickness significantly 1 week after treatment (t-test, *P<0.05), but the decrease was no longer significant 2 weeks later. (C) The treated eyes did not show a significant decrease in VEGF expression up to 3 weeks after the treatment. CNV, choroidal neovascularization.

  • Table 1.
Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

RSSRSS

Keywords

  • Choroidal neovascularization (CNV)
  • Vascular endothelial growth factor (VEGF)
  • Electron microscopy (EM)
  • Bevacizumab
  • Angiogenesis
  • Age-related macular degeneration (AMD)

 Download PDF

Email

Thank you for your interest in spreading the word on Biology Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A new rat model of treatment-naive quiescent choroidal neovascularization induced by human VEGF165 overexpression
(Your Name) has sent you a message from Biology Open
(Your Name) thought you would like to see the Biology Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Research Article
A new rat model of treatment-naive quiescent choroidal neovascularization induced by human VEGF165 overexpression
Shan Liu, Antje K. Biesemeier, Alexander V. Tschulakow, Harsh V. Thakkar, Sylvie Julien-Schraermeyer, Ulrich Schraermeyer
Biology Open 2020 9: bio048736 doi: 10.1242/bio.048736 Published 11 June 2020
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Research Article
A new rat model of treatment-naive quiescent choroidal neovascularization induced by human VEGF165 overexpression
Shan Liu, Antje K. Biesemeier, Alexander V. Tschulakow, Harsh V. Thakkar, Sylvie Julien-Schraermeyer, Ulrich Schraermeyer
Biology Open 2020 9: bio048736 doi: 10.1242/bio.048736 Published 11 June 2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article Navigation

  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • Acknowledgements
    • Footnotes
    • References
  • Figures & tables
  • Supp info
  • Info & metrics
  • eLetters
  • PDF + SI
  • PDF

Related articles

Cited by...

More in this TOC section

  • Tetraspanin18 regulates angiogenesis through VEGFR2 and Notch pathways
  • Segregation of brain and organizer precursors is differentially regulated by Nodal signaling at blastula stage
  • Unique histological features of the tail skin of cotton rat (Sigmodon hispidus) related to caudal autotomy
Show more RESEARCH ARTICLE

Similar articles

Other journals from The Company of Biologists

Development

Journal of Cell Science

Journal of Experimental Biology

Disease Models & Mechanisms

Advertisement

Biology Open and COVID-19

We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.

Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.


New funding scheme supports sustainable events

As part of our Sustainable Conferencing Initiative, we are pleased to announce funding for organisers that seek to reduce the environmental footprint of their event. The next deadline to apply for a Scientific Meeting grant is 26 March 2021.


Future Leader Review – early neurodegeneration of Alzheimer’s disease

A new Future Leader Review from Olayemi Olajide, Marcus Suvanto and Clifton Andrew Chapman evaluates the molecular mechanisms that may explain the vulnerability and susceptibility of the entorhinal cortex to early neurodegeneration during the pathogenesis of Alzheimer's disease.

Find out more about our Future Leader Reviews – they are an exclusive opportunity for early-career researchers who want to establish themselves in their field.


First author interviews

Catch up on our latest first author interviews to go behind the scenes of our latest research, find out more about the authors and hear from early-career researchers themselves how they’re finding life at the bench.


Retinal degeneration in Drosophila

Thank you to Elisabeth Knust and her team for their confocal image of a longitudinal section of an adult Drosophila retina, which brightens the cover of our latest issue. Read the research behind the cover.

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Interviews
  • Sign up for alerts

About us

  • About BiO
  • Editors and Board
  • Editor biographies
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contact

  • Contact BiO
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992